DEA has prepared this product primarily for law enforcement counterparts (state, local and tribal) and public safety and protection officials with a focus on enduring and emerging threats at both the national and regional levels. This report represents what will be the first of regular STREET reports prepared for and...

U.S. Attorney’s Office, District of Columbia Press Conference - November 20, 2023 Fentanyl is the greatest threat to Americans today. It is devastating families across our country and killing Americans from all walks of life. And it is the leading cause of death for Americans between the ages of 18...

This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is August 19, 2022 to November 2, 2022 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document...

This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of November 3, 2022 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...

This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of November 6, 2023 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...

This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of September 29, 2023 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...

DEA is steadfastly committed to ensuring that all Americans get access to needed medications, while also ensuring patient safety. Stimulants are important medications for both children and adults. They are also Schedule II controlled substances that can be highly addictive and that require the greatest care in prescribing. When inappropriately...

Dear Americans, On August 1, 2023, I wrote to you with FDA Commissioner Robert Califf to address the lack of availability of certain prescription stimulant medications. As we said then, the U.S. Food and Drug Administration (FDA)and the Drug Enforcement Administration (DEA) recognize the important role that prescription stimulants play...

INTREPID confirms both liquid veterinary preparations and powdered xylazine are being used to adulterate fentanyl. INTREPID observed chemical markers in xylazine seizures that can assist in determining precursors, synthetic routes, and potentially connecting cases.

DEA received more than 38,000 comments on its proposed telemedicine rules and recently held two days of public listening sessions related to those rules. We continue to carefully consider the input received and are working to promulgate a final set of telemedicine regulations by the fall of 2024, giving patients...